Investment ThemesDetailed Quotes
Infectious Disease
Watchlist
- 0.000
- 0.0000.00%
Close Sep 10 09:30 ET
0.000High0.000Low
0.000Open0.000Pre Close0Volume--Rise27.91P/E (Static)0.00Turnover--Flatline0.00%Turnover Ratio2.42TMarket Cap--Fall2.36TFloat Cap
Constituent Stocks: 18Top Rising: MRNA+3.49%
literally. will it ever go down ?
More volatility can be expected with two key economic reports coming up - Aug CPI price on Wednesday, and PPI on Thursday.
$Invesco QQQ Trust (QQQ.US)$ $S&P 500 Index (.SPX.US)$ $Apple (AAPL.US)$ $Palantir (PLTR.US)$ $Johnson & Johnson (JNJ.US)$ $Coca-Cola (KO.US)$ $FuboTV (FUBO.US)$ $PepsiCo (PEP.US)$ $XPeng (XPEV.US)$ $Nike (NKE.US)$ $Yum! Brands (YUM.US)$ $Bank of America (BAC.US)$ $JPMorgan (JPM.US)$ $Financial Select Sector SPDR Fund (XLF.US)$
The "September effect" appears to be resurfacing, with the S&P 500 down 3.14% month-to-date as of Monday's close, now in the second week of September.
Last week, we published "Wall Street is Bracing for September Curse Again. What's New and How to Tackle It," outlini...
👀 stay tuned for updates on meeting outcomes
See 👇 for further info.
🚨 This Week’s AdCom:
$Iterum Therapeutics (ITRM.US)$ : Meeting ongoing 🤔
⇨ Sulopenem
‣ uUTI (Uncomplicated Urinary Tract Infection)
‣ AdCom: 9/9/24
🚨 Last Week’s PDUFAs:
$Travere Therapeutic (TVTX.US)$ : Approved 9/5 🎉
⇨ FILSPARI (Sparsentan)
‣ IgA nephropathy (IgAN)
‣ PDUFA: 9/5/24
$Avadel Pharmaceuticals (AVDL.US)$ : Awaiting decision 🤔
⇨ LUMRYZ (sodium oxybate)
‣...
Market Snapshot
The Dow Jones Industrial Average rose 484.18 points, or 1.20%, to 40,829.59, the S&P 500 gained 62.63 points, or 1.16%, to 5,471.05 and the...
nice, I didnt jinx it this time.
I still have a few shares to sell…
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ traded up 1.16% the $Dow Jones Industrial Average (.DJI.US)$ climbed 1.20%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 1.16%.
MACRO
This week in macro, investors are waiting for slimmer pickings during the blackout period for Fed press commentary. FOMC members are barre...
Vir Biotechnology Announces Closing of Exclusive Worldwide License Agreement With Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-Cell Engagers
No comment yet